chr14-50912167-G-A

Variant summary

Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2

The ENST00000216392.8(PYGL):​c.1757C>T​(p.Thr586Met) variant causes a missense change. The variant allele was found at a frequency of 0.000584 in 1,614,072 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T586T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00044 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00060 ( 2 hom. )

Consequence

PYGL
ENST00000216392.8 missense

Scores

9
7
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 6.86
Variant links:
Genes affected
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -3 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.764
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PYGLNM_002863.5 linkuse as main transcriptc.1757C>T p.Thr586Met missense_variant 14/20 ENST00000216392.8 NP_002854.3
PYGLNM_001163940.2 linkuse as main transcriptc.1655C>T p.Thr552Met missense_variant 13/19 NP_001157412.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PYGLENST00000216392.8 linkuse as main transcriptc.1757C>T p.Thr586Met missense_variant 14/201 NM_002863.5 ENSP00000216392 P1P06737-1
PYGLENST00000532462.5 linkuse as main transcriptc.1757C>T p.Thr586Met missense_variant 14/201 ENSP00000431657
PYGLENST00000544180.6 linkuse as main transcriptc.1655C>T p.Thr552Met missense_variant 13/192 ENSP00000443787 P06737-2

Frequencies

GnomAD3 genomes
AF:
0.000440
AC:
67
AN:
152188
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000794
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000418
AC:
105
AN:
251452
Hom.:
1
AF XY:
0.000397
AC XY:
54
AN XY:
135900
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000416
Gnomad NFE exome
AF:
0.000756
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000599
AC:
875
AN:
1461884
Hom.:
2
Cov.:
34
AF XY:
0.000567
AC XY:
412
AN XY:
727244
show subpopulations
Gnomad4 AFR exome
AF:
0.000179
Gnomad4 AMR exome
AF:
0.000134
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000356
Gnomad4 NFE exome
AF:
0.000739
Gnomad4 OTH exome
AF:
0.000348
GnomAD4 genome
AF:
0.000440
AC:
67
AN:
152188
Hom.:
1
Cov.:
32
AF XY:
0.000417
AC XY:
31
AN XY:
74356
show subpopulations
Gnomad4 AFR
AF:
0.000145
Gnomad4 AMR
AF:
0.000262
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000283
Gnomad4 NFE
AF:
0.000794
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000650
Hom.:
1
Bravo
AF:
0.000499
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000412
AC:
50
EpiCase
AF:
0.000491
EpiControl
AF:
0.000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Glycogen storage disease, type VI Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 10, 2023- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 23, 2023The c.1757C>T (p.T586M) alteration is located in exon 14 (coding exon 14) of the PYGL gene. This alteration results from a C to T substitution at nucleotide position 1757, causing the threonine (T) at amino acid position 586 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicJun 20, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.36
BayesDel_addAF
Benign
-0.033
T
BayesDel_noAF
Uncertain
0.090
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.64
.;.;D
Eigen
Pathogenic
0.77
Eigen_PC
Pathogenic
0.74
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
D;D;D
M_CAP
Uncertain
0.16
D
MetaRNN
Pathogenic
0.76
D;D;D
MetaSVM
Pathogenic
0.90
D
MutationAssessor
Uncertain
2.6
.;.;M
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.68
T
PROVEAN
Pathogenic
-4.8
D;D;D
REVEL
Pathogenic
0.73
Sift
Uncertain
0.028
D;D;D
Sift4G
Benign
0.10
T;T;T
Polyphen
1.0
.;.;D
Vest4
0.74
MVP
0.98
MPC
0.54
ClinPred
0.62
D
GERP RS
4.7
Varity_R
0.52
gMVP
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144989341; hg19: chr14-51378885; API